GlassScriptPhysician profile
David Litvak
NPI 1750458758
$9,938.44
in general payments reported to CMS, 2019-2025
16 companies · $279 in 2025
The $279 reported for 2025 was less than what a typical Surgical Oncology provider received nationally (typical 2025 total: $288).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $330 · 2020: $2,218 · 2021: $406 · 2022: $3,000 · 2024: $3,705 · 2025: $279.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $3,000 · Food and Beverage: $685 · Travel and Lodging: $299.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $3,000.00 |
| Food and Beverage | $684.79 |
| Travel and Lodging | $298.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $8,682.97 | 2020-2024 | |
| Veryan Medical Incorporated | $213.42 | 2021 | |
| Davol INC. | $192.66 | 2021 | |
| Urgo Medical North America, LLC | $171.55 | 2024 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap |
| Aroa Biosurgery Incorporated | $151.18 | 2025 | |
| Integra Lifesciences Corporation | $102.19 | 2025 | Integra, Integra Dermal Regeneration Template, Omnigraft |
| Pharmacyclics LLC, An Abbvie Company | $97.51 | 2019-2020 | |
| Lilly USA, LLC | $83.29 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $46.56 | 2019-2020 | |
| Tesaro, INC. | $46.19 | 2019 | |
| Merck Sharp & Dohme LLC | $45.01 | 2019 | |
| Ethicon US, LLC | $27.25 | 2019 | |
| Kyowa Kirin, INC. | $25.25 | 2025 | |
| Glaxosmithkline, LLC. | $18.90 | 2020 | |
| Lexicon Pharmaceuticals, INC. | $18.79 | 2020 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Celgene Corporation | $15.72 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Litvak listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.